Sfoglia per AUTORE
CAVALLA P
Collezione AOU Città della Salute di Torino

  

Items : 26

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. in Journal of neurology / J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Solaro C; Cocco E; Moccia M; Tomassini V; Lanzillo R; Malucchi S; Paolicelli D; De Luca G; Laroni A; Calabrese M; Gajofatto A; Buttari F; Guaschino C; Radaelli M; Fantozzi R; Clerico M; Di Sabatino E; Cavalla P; Nociti V; Lorefice L; Gallo A; Prosperini L; Maniscalco GT; Ragonese P; Ferraro D; Di Filippo M; Gasperini C;

Long-term modifications of the peripheral immune repertoire after switching from sequestering disease-modifying treatments in multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2024 Dec;30(14):1737-1754. doi: 10.1177/13524585241284846. Epub 2024 Oct 7.
2024
AOU Città della Salute di Torino

Vercellino M; Marasciulo S; Ricotti E; Rolando A; Bosa C; Garelli P; Gallina V; Vaula G; Calvo A; Cavalla P;

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2024 Aug;11(8):2008-2015. doi: 10.1002/acn3.52118. Epub 2024 Jul 5.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Brescia Morra V; Cocco E; Torri Clerici V; Spitaleri D; Clerici R; Vianello M; Quatrale R; Di Sapio A; Montepietra S; Gallo A; Bellantonio P; Gallo P; De Luca G; Cavalla P; Romano S; Granella F; Patti F; Foschi M; Inglese M; Portaccio E; Paolicelli D; Guerra T; Lucisano G; Iaffaldano P; Marfia GA; Boccia VD; Filippi M; Amato MP; Trojano M; et alii...

Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2023 Nov;29(13):1526-1539. doi: 10.1177/13524585231199031. Epub 2023 Sep 23.
2023
ASL Torino 5
AOU Città della Salute di Torino

Morana G; Calvo A; Rolando A; Garelli P; Valentini C; Bosa C; Marasciulo S; Sciortino P; Lequio L; De Negri F; Costantini G; Cogoni M; Cavalla P; Vercellino M;

SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Jun;74:104715. doi: 10.1016/j.msard.2023.104715. Epub 2023 Apr 10.
2023
AOU Città della Salute di Torino

Vercellino M; Bosa C; Alteno A; Muccio F; Marasciulo S; Garelli P; Cavalla P;

Sars-CoV2 infection in pregnant women with multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2023 Aug;29(9):1090-1098. doi: 10.1177/13524585231176174. Epub 2023 May 26.
2023
ASL Cuneo 2
ASL Città di Torino
AOU Città della Salute di Torino

Amato MP; Tutuncu M; Vaula G; Sormani MP; Trojano M; Tedeschi G; Strumia S; Teatini F; Sartori A; Scandellari C; Sen S; Siva A; Salvetti M; Radaelli M; Puthenparampil M; Pesci I; Pucci E; Perini P; Orlandi R; Patti F; Marfia GA; Moiola L; Masciulli C; Milano E; Mantero V; Marangoni S; Lorefice L; L'Episcopo MR; Lanzillo R; et alii...

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study. in Frontiers in immunology / Front Immunol. 2023 Dec 19;14:1327947. doi: 10.3389/fimmu.2023.1327947. eCollection 2023.
2023
AOU Città della Salute di Torino

Vecchio D; Teunissen C; Rot U; Schnabl C; Rosenstein I; Presslauer S; Petersen T; van Pesch V; Milosavljevic D; Hassler M; Leurs C; Gaetani L; Di Filippo M; Emerši? A; Christiansen M; Cavalla P; Hegen H; Berek K; Vercellino M; Deisenhammer F;

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements. in Biomolecules / Biomolecules. 2022 May 7;12(5):677. doi: 10.3390/biom12050677.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Ferraro D; Sola P; Trenti T; Cucinelli MR; Gastaldi M; Vitetta F; Caropreso P; Cavalla P; De Michele T; Nociti V; Villa A; Sala A; Nicolò C; Di Filippo M; Lamonaca M; Crespi I; Schirru L; Corsini E; Cocco E; On Behalf Of Rirems Rising Researchers In Ms; Bernardi G; Bedin R; Natali P;

Impact of COVID-19 lockdown on progressive multiple sclerosis patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2022 May;43(5):2943-2946. doi: 10.1007/s10072-022-05909-z. Epub 2022 Jan 24.
2022
AOU Città della Salute di Torino

Cavalla P; Marasciulo S; Petracca M; Schillaci V; Alteno A; Bosa C; Vercellino M;

Acute and chronic synaptic pathology in multiple sclerosis gray matter. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2022 Mar;28(3):369-382. doi: 10.1177/13524585211022174. Epub 2021 Jun 14.
2022
AOU Città della Salute di Torino

Corona C; Giordana MT; Chiò A; Casalone C; Crociara P; Pasanisi MB; Vallino-Costassa E; Bosa C; Grifoni S; Marasciulo S; Vercellino M; Cavalla P;

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

Dietary habits, nutritional status and risk of a first demyelinating event: an incident case-control study in a southern European cohort. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2022 Jul;43(7):4373-4380. doi: 10.1007/s10072-022-05908-0. Epub 2022 Feb 15.
2022
ASL Torino 5
AOU Città della Salute di Torino

Vercellino M; Cuffini E; Panizzolo S; De Francesco A; Chiò A; Costantini G; Durelli P; Alteno A; Schillaci V; Bosa C; Pasanisi MB; Cavalla P; Maietta D; Golzio P;

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Cocco E; Gasperini C; Solaro C; Gazzola P; Gallo A; Maniscalco GT; Paolicelli D; Calabrese M; Borrelli A; Tomassini V; De Luca G; Clerico M; Boffa L; Lanzillo R; Moccia M; Ferraro D; Gajofatto A; Prosperini L; Fantozzi R; Buttari F; Laroni A; Lorefice L; Radaelli M; Nociti V; Torri Clerici V; Cavalla P; Annovazzi P; Malucchi S; et alii...

Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Apr;60:103740. doi: 10.1016/j.msard.2022.103740. Epub 2022 Mar 12.
2022
AOU Città della Salute di Torino

De Martino A; Cavalla P; Valentino P; Marfia GA; Lavorgna L; Miele G; Maida E; Abbadessa G; Bonavita S;

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study. in Journal of the neurological sciences / J Neurol Sci. 2021 May 15;424:117385. doi: 10.1016/j.jns.2021.117385. Epub 2021 Mar 6.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Frangiamore R; Laroni A; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Cocco E; Lorefice L; Maniscalco GT; Curti E; Lavorgna L; Abbadessa G; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; De Mercanti SF; Cavalla P; Costantini G; Capra R; Sormani MP; Clerico M;

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Aug 2;18(15):8163. doi: 10.3390/ijerph18158163.
2021
AOU Città della Salute di Torino

Abbadessa G; Miele G; Cavalla P; Valentino P; Marfia GA; Signoriello E; Landi D; Bosa C; Vercellino M; De Martino A; Missione R; Sparaco M; Lavorgna L; Lus G; Bonavita S;

Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study. in European journal of neurology / Eur J Neurol. 2021 Apr;28(4):1299-1307. doi: 10.1111/ene.14672. Epub 2021 Jan 12.
2021
AOU Città della Salute di Torino

Buscarinu MC; Pinardi F; Farina D; De Luca G; Fantozzi R; Cerqua R; Zagaglia S; Buttari F; Lanzillo R; Moccia M; Paolicelli D; Iaffaldano P; Manni A; Amato MP; Righini I; Tortorella C; Tomassini V; Ferraro D; Nociti V; De Fino C; Di Carmine C; Totaro R; Nicoletti CG; Landi D; Prosperini L; Gajofatto A; Annovazzi P; Ragonese P; Cavalla P; et alii...

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series. in Frontiers in neurology / Front Neurol. 2021 Oct 20;12:691616. doi: 10.3389/fneur.2021.691616. eCollection 2021.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cavalla P; Clerico M; Schillaci V; Bosa C; Alteno A; De Mercanti SF; Vercellino M;

2021
AO Cuneo
ASL Città di Torino
ASL Torino 3
AOU Città della Salute di Torino

Golini N; Cantello R; Leone MA; D'Alfonso S; Barizzone N; Bertolotto A; Richiardi P; Grasso MF; Gnavi R; Picariello R; Cavalla P; Alboini PE;

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):914-920. doi: 10.1136/jnnp-2019-322480. Epub 2020 Jul
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Spinicci G; Spitaleri D; Sessa E; Rovaris M; Righini I; Pontecorvo S; Petrucci L; Matta M; Paolicelli D; Maniscalco GT; Lus G; Lanzillo R; Guareschi A; Gasperini C; Gajofatto A; Esposito F; Danni MC; Cottone S; Centonze D; Costantino G; Castelli L; Cavalla P; Capello E; Bruno Bossio R; Brescia Morra V; Bonavita S; Bianco A; Bergamaschi R; Annunziata P; et alii...

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Laroni A; Frangiamore R; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Lorefice L; Cocco E; Curti E; Maniscalco GT; Lavorgna L; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; Iudicello M; De Mercanti SF; Clerico M; Cavalla P; Costantini G; Sormani MP; Capra R;

Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders. in Journal of neuroimmunology / J Neuroimmunol. 2020 Feb 15;339:577122. doi: 10.1016/j.jneuroim.2019.577122. Epub 2019 Dec 3.
2020
AOU Città della Salute di Torino

Mengozzi G; Giordana MT; Costantini G; Alteno A; Schillaci V; Pasanisi MB; Bosa C; Limoncelli S; Caropreso P; Cavalla P; Vercellino M;

Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2018 Jul;24(8):1133-1137. doi: 10.1177/1352458518763095. Epub 2018 Apr 30.
2018
AOU Città della Salute di Torino

Bandini F; Vercellino M; Laroni A; Uccelli A; Cavalla P; Giordana MT; Mancardi G; Giordana MT; Cavalla P; Uccelli A; Laroni A; Bandini F; Vercellino M; Mancardi G;

Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study. in Journal of neuroimmunology / J Neuroimmunol. 2017 Nov 15;312:49-58. doi: 10.1016/j.jneuroim.2017.09.004. Epub 2017 Sep 8.
2017
AOU Città della Salute di Torino

Vercellino M; Trebini C; Capello E; Mancardi GL; Giordana MT; Cavalla P;

2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Paolicelli D; Cavalla P; Sola P; Vitetta F; Realmuto S; Salemi G; Bianchi A; Ghezzi A; Lanzillo R; Brescia Morra V; Gned D; Piazza F; De Mercanti SF; Schiavetti I; Clerico M; Trojano M; Sormani MP; Durelli L;